Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats

Journal of Applied Toxicology

Volumn 24, Issue 1, 2004, Pages 27-35

  Özen, Süleyman ^a   Akyol, Ömer ^b   Iraz, Mustafa ^b   Söǧüt, Sadik ^c   Özuǧurlu, Fikret ^d   Özyurt, Hüseyin ^d   Odaci, Ersan ^e   Yildirim, Zeki ^b  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

^b INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c MUSTAFA KEMAL UNIVERSITY   (Turkey)

^d GAZIOSMANPASA UNIVERSITY   (Turkey)

^e ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Caffeic acid phenethyl ester; Catalase; Cisplatin; Dismutase; Glutathione peroxidase; Malondialdehyde; Myeloperoxidase; Nephrotoxicity; Nitric oxide; Superoxide

Indexed keywords

AMIFOSTINE; ANTIOXIDANT; CAFFEIC ACID PHENETHYL ESTER; CATALASE; CISPLATIN; CREATININE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MYELOPEROXIDASE; NITRIC OXIDE; PROPOLIS; SCAVENGER; SUPEROXIDE DISMUTASE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SWELLING; CELL VACUOLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; KIDNEY NECROSIS; KIDNEY PARENCHYMA; KIDNEY TUBULE DAMAGE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; TISSUE LEVEL; UREA NITROGEN BLOOD LEVEL;

ANIMALS; BLOOD UREA NITROGEN; CAFFEIC ACIDS; CATALASE; CISPLATIN; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FEMALE; FREE RADICAL SCAVENGERS; GLUTATHIONE PEROXIDASE; KIDNEY; KIDNEY FAILURE, ACUTE; NITRIC OXIDE; OXIDATIVE STRESS; PHENYLETHYL ALCOHOL; PROPOLIS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

PROPOLIS;

EID: 0442326350     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jat.941     Document Type: Article

References (44)

1. Aebi H. 1974. Catalase. In: Methods of Enzymatic Analysis, Bergmeyer HU (ed.). Academic Press: New York; 673-677.
2. Anand AJ, Bashey B. 1993. Newer insights into cisplatin nephrotoxicity. Ann. Pharmacother. 27: 1519-1525.
3. Baliga R, Zhang Z, Baliga M, Shah SV. 1998. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int. 53: 394-401.
4. Chatterjee PK, Patel NSA, Kvale EO, Cuzzocrea S, Brown PA, Stewart KN, Mota-Filipe H, Thiemermann C. 2002. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int. 61: 862-871.
5. Chiao C, Carothers AM, Grunberger D, Solomon G, Preston GA, Barrett JC. 1995. Apoptosis and altered redox state induced by caffeic acid phenethyl ester (CAPE) in transformed rat fibroblast cells. Cancer Res. 55: 3576-3583.
6. Cortas NK, Wakid NW. 1990. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin. Chem. 36: 1440-1443.
7. Durak I, Yurtarslani Z, Canbolat O, Akyol O. 1993. A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clin. Chim. Acta. 214: 103-104.
8. Fadillioglu E, Erdogan H, Sogut S, Kuku I. 2003. Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats. J. Appl. Toxicol. 23: 71-74.
9. Frenkel K, Wei H, Bhimani R, Ye J, Zadunaisky JA, Huang M, Ferraro T, Conney AH, Grunberger D. 1993. Inhibition of tumor promoter-mediated processes in mouse skin and bovine lens by caffeic acid phenethyl ester. Cancer Res. 53: 1255-1261.
10. Goligorsky MS, Brodsky SV, Noiri E. 2002. Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int. 61: 855-861.
11. Grilli M, Chiu JJS, Lenardo MJ. 1993. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143: 1-62.
12. Grunberger D, Banerjee R, Eisinger K, Oltz EM, Efros L, Caldwell M, Estevez V, Nakanishi K. 1988. Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia. 44: 230-232.
13. Hara M, Yoshida M, Nishijima H, Yokosuka M, Ligo M, Ohtani-Kaneko R, Shimada A, Hasegawa T, Akama Y, Hirata K. 2001. Melatonin, a pineal secretory product with antioxidant properties, protects against cisplatin-induced nephrotoxicity in rats. J. Pineal Res. 30: 129-138.
14. Hepsen IF, Bayramlar H, Gultek A, Ozen S, Tilgen F, Evereklioglu C. 1997. Caffeic acid phenethyl ester to inhibit posterior capsule opacification in rabbits. J. Cataract Refract Surg. 23: 1572-1576.
15. Hepsen IF, Er H, Cekic O. 1999. Topically applied water extract of propolis to suppress corneal neovascularization in rabbits. Ophthal. Res. 31: 426-431.
16. Herbert V, shaw S, Jayatilleke E, Stopler-Kasdan T. 1994. Most free-radical injury is iron-related: It is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine and apoferritin. Stem Cells 12: 289-303.
17. Huang Y, Zhou S, Qui L, Wu J, Xu C. 1997. Effects of zinc gluconate on nephrotoxicity and glutathione metabolism disorder induced by cisplatin in mice. Drug Metab. Drug Interact. 14: 41-46.
18. Ilhan A, Koltuksuz U, Ozen S, Uz E, Ciralik H, Akyol O. 1999. The effects of caffeic acid phenethyl ester (CAPE) on spinal cord ischemia/reperfusion injury in rabbits. Eur. J. Cardiothorac. Surg. 16: 458-463.
19. Irmak MK, Koltuksuz U, Kutlu NO, Yagmurca M, Ozyurt H, Karaman A, Akyol O. 2001. The effect of caffeic acid phenethyl ester on ischemia-reperfusion injury in comparison with alpha-tocopherol in rat kidneys. Urol. Res. 29: 190-193.
20. Kelly KJ, Meehan SM, Colvin RB, Williams WW, Bonventre JV. 1999. Protection from toxicant-mediated renal injury in the rat with anti-CD54 antibody. Kidney Int. 56: 922-931.
21. Khayyal MT, el-Ghazaly MA, el-Khatip AS. 1993. Mechanisms involved in the antiinflammatory effect of propolis extract. Drugs Exp. Clin. Res. 19: 197-203.
22. Kirkebo'en KA, Strand QA. 1999. The role of nitric oxide in sepsis - an overview. Acta Anaesthesiol. Scand 43: 275-288.
23. Koltuksuz U, Ozen S, Uz E, Aydinc M, Karaman A, Gultek A, Akyol O, Gursoy MH, Aydin E. 1999. Caffeic acid phenethyl ester (CAPE) prevents intestinal reperfusion injury in rats. J. Pediatr. Surg. 34: 1458-1462.
24. Koltuksuz U, Irmak MK, Karaman A, Uz E, Var A, Ozyurt H, Akyol O. 2000. Testicular nitric oxide levels after unilateral testicular torsion-detorsion in rats pretreated with caffeic acid phenethyl ester. Urol. Res. 28: 360-363.
25. Lowry O, Rosenbraugh N, Farr L, Randall R. 1951. Protein measurement with the Folin-phenol reagent. J. Biol. Chem. 183: 265-275.
26. Muller DN, Dechend R, Mervaala EM, Park JK, Schmidt F, Fiebeler A, Theuer J, Breu V, Ganten D, Haller H, Luft FC. 2000. NF-kappa B inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension. 35: 193-201.
27. Natarajan K, Singh S, Burke TR Jr, Grunberger D, Aggarwal BB. 1996. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB. Proc. Natl. Acad. Sci. USA. 93: 9090-9095.
28. Orban Z, Mitsiades N, Burke TR Jr, Tsokos M, Chrousos GP. 2000. Caffeic acid phenethyl ester induces leukocyte apoptosis, modulates nuclear factor-kappa B and suppresses acute inflammation. Neuroimmunomodulation. 7: 99-105.
29. Orditura M, De Vita F, Roscigno A, Infusino S, Auriemma A, Iodice P, Ciaramella F, Abbate G, Catalano G. 1999. Amifostine: a selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity (Review). Oncol. Rep. 6: 1357-1362.
30. Ozyurt H, Irmak MK, Akyol O, Sogut S. 2001. Caffeic acid phenethyl ester changes the indices of oxidative stress in serum of rats with renal ischemia-reperfusion injury. Cell Biochem. Funct. 19: 259-263.
31. Paglia DE, Valentine WN. 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70: 158-170.
32. Safirstein RL. 1999. Lessons learned from ischemic and cisplatin-induced nephrotoxicityu in animals. Renal Failure. 21: 359-361.
33. Sud'ina GF, Mirzoeva OK, Pushkareva MA, Korshunova GA, Sumbatyan NV, Varfolomeev SD. 1993. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett. 329: 21-24.
34. Sugihara K, Gemba M. 1986. Modification of cisplatin toxicity by antioxidants. Jpn. J. Pharmacol. 40: 353-355.
35. Sun Y, Oberley LW, Li Y. 1988. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 34: 497-500.
36. Tome LA, Yu L, de Castro I, Campos SB, Seguro AC. 1999. Beneficial and harmful effects of L-arginine on renal ischaemia. Nephrol. Dial. Transpl. 14: 1139-1145.
37. Townsend AJ, Leone-Kabler S, Haynes RL, Wu Y, Szweda L, Bunting KD. 2001. Selective protection by stably transfected human ALDH3A1 (but not human ALDH1A1) against toxicity of aliphatic aldehydes in V79 cells. Chem. Biol. Interact. 130-132: 261-273.
38. Tsutsumishita Y, Onda T, Okada K, Takeda M, endou H, Futaki S, Niwa M. 1998. Involvement of H2O2 production in cisplatin-inducednephrotoxicity. Biochem. Biophys. Res. Commun. 242: 310-312.
39. Walker LM, Walker PD, Imam SZ, Ali SF, Mayeux PR. 2000. Evidence for peroxynitrite formation in renal ischemia-reperfusion injury: studies with the inducible nitric oxide synthase inhibitor L-N(6)-(1-iminoethyl)lysine. J. Pharmacol. Exp. Ther. 295: 417-422.
40. Wangsiripaisan A, Gengaro PE, Nemenoff RA, Ling H, Edelstein CL, Schrier RW. 1999. Effect of nitric oxide donors on renal tubular epithelial cell-matrix adhesion. Kidney Int. 55: 2281-2288.
41. Wasowicz W, Neve J, Peretz A. 1993. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin. Chem. 39: 2522-2526.
42. Wei H, Frenkel K. 1993. Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters. Carcinogenesis. 14: 1195-1201.
43. Yildirim Z, Sogut S, Odaci E, Iraz M, Ozyurt H, Kotuk M, Akyol O. 2003. Oral erdosteine administration attenuates cisplatin-induced renal tubular damage in rats. Pharmacol. Res. 47: 49-156.
44. Zhang JG, Viale M, Esposito M, Lindup WE. 1999. Tiopronin protects against the nephrotoxicity of cisplatin in the rat. Hum. Exp. Toxicol. 18: 713-717.